| P2093 | author name string | B Shan | |
| | Y Wu | |
| | G K Stalla | |
| | E Arzt | |
| | M Lange | |
| | M J Perone | |
| | U Renner | |
| | C Schaaf | |
| | D Kuhlen | |
| | D Utpadel | |
| | S Curic | |
| P2860 | cites work | Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals | Q24631327 |
| | Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas | Q28140396 |
| | Bioavailability of curcumin: problems and promises | Q28257125 |
| | Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo | Q33875921 |
| | Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy | Q33880237 |
| | Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention | Q33892008 |
| | Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions | Q33956003 |
| | Multitargeting by curcumin as revealed by molecular interaction studies | Q34042485 |
| | Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis | Q34142043 |
| | Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO | Q34324259 |
| | Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials | Q34622690 |
| | Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A. | Q34631013 |
| | A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors | Q34928908 |
| | Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas | Q35747010 |
| | Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK | Q35751980 |
| | Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth | Q35765074 |
| | Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration | Q36694655 |
| | Cancer cell signaling pathways targeted by spice-derived nutraceuticals | Q36819371 |
| | Cell growth regulation. | Q36849498 |
| | EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. | Q36950656 |
| | Targeted drug therapy for meningiomas | Q36981530 |
| | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 |
| | NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth | Q37275182 |
| | Pathological classification and molecular genetics of meningiomas. | Q37784454 |
| | Medical therapies for meningiomas | Q37785808 |
| | Angiogenesis in meningiomas | Q37835102 |
| | The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. | Q37870199 |
| | Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways | Q39477003 |
| | The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma | Q39503654 |
| | Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway | Q39607089 |
| | Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells | Q39735326 |
| | Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells | Q39738679 |
| | Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo | Q39804379 |
| | Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). | Q40031444 |
| | Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways | Q40152110 |
| | Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma | Q40397270 |
| | Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance | Q45122000 |
| | Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas | Q45167839 |
| | Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. | Q46036124 |
| | Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression. | Q46093010 |
| | Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel | Q46439248 |
| | Meningioma | Q46700774 |
| | Expression of somatostatin receptor subtypes in human brain tumors | Q48017831 |
| | Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. | Q54559220 |
| | Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas | Q58862180 |
| | Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases | Q73193827 |
| | Curcumin: a component of the golden spice, targets multiple angiogenic pathways | Q83059302 |
| P433 | issue | 3 | |
| P921 | main subject | apoptotic process | Q14599311 |
| | curcumin | Q312266 |
| P304 | page(s) | 385-396 | |
| P577 | publication date | 2013-05-11 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas | |
| P478 | volume | 113 | |